Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So for the Zacks downgrade on 2.13 (http://www.dailypolitical.com/finance/stock-market/antares-pharma-lowered-to-underperform-at-zacks-atrs.htm), does anybody have an actual copy of it that they can send me?
rymankoly: do you have a link where i can see that?
Thanks, i find that curious. 1.15.13 , 2.13.13..i thot you mite have meant 1.15.12 at first..but nope it's 2013..
bio_pete: thanks. to find out if their IR person can get me a copy of the zacks downgrade that occurred on 2.13 apparently: http://www.dailypolitical.com/finance/stock-market/antares-pharma-lowered-to-underperform-at-zacks-atrs.htm
Investor relations? What is the direct telephone # for it or email addy? I just called the atrs # but didn't hear any option for IR on the menu. Chose to speak to the receptionist but they were not available. Did leave a message. See if i get a call back
also, what do you think of how there was some form 4 selling on atrs by the ceo and cfo at $4~? i hope they will buy these shares back now as the price is cheaper?
i don't think the "technical damage" you reference is that important. I think the key thing now is to have very heavy support on the 3.50, if there's enuf willing buyers there, that that is the first step in a move upwards back it's prior trading prices
Well if the sales #'s are going to be good, the stock should move up in price. Thus the CEO financing (a) 3 weeks before the sales #'s come out, and (b) and at an all-time low to boot (!) lead me to think the sales #'s are below expectation.
Long trade idea: june $2.50 strike puts. sell at 40c on bid. Gives a cost of 2.50-.40=2.10 per share if one is exercised at expiry in june. If stock is above 2.50$/share in june and the options not exercised, one keeps the 40c/share as profit. Thoughts?
CRME d/d. Has been below the price today and yesterday where the CEO bot 1.75m shares on dec.12. CEO bot at .406 and .408. Was featured in a seeking alpha by buysellshort on 1.31: "The confidence shown by the CEO in his stock purchase could be a sign a deal is in the pipeline."
links:
- ceo: http://www.cardiome.com/about-us/management-team
- purchase: http://canadianinsider.com/node/7?menu_tickersearch=Cardiome+Pharma+Corp.+%7C+COM
- seeking alpha article: http://seekingalpha.com/article/1146601-4-speculative-biotech-stocks-to-consider
CRME d/d. Has been below the price today and yesterday where the CEO bot 1.75m shares on dec.12. CEO bot at .406 and .408. Was featured in a seeking alpha by buysellshort on 1.31: "The confidence shown by the CEO in his stock purchase could be a sign a deal is in the pipeline."
links:
- ceo: http://www.cardiome.com/about-us/management-team
- purchase: http://canadianinsider.com/node/7?menu_tickersearch=Cardiome+Pharma+Corp.+%7C+COM
- seeking alpha article: http://seekingalpha.com/article/1146601-4-speculative-biotech-stocks-to-consider
How's that true?? What if the thing breaks $1.00 in the next 2 weeks? A 20-40% loss isn't comfortable for most investors
Unfortunately? I think a reverse split is positive if it maintains the nasdaq listing. Nasdaq has a lot more prestige than OTC
Well the people that are predicting it's going below $1.00 on twitter, I see them saying that they are short shares or have downward exposure via long put options.
Yes, no disputing that shares are being bot up (and shares are also being dumped). But i think the more fundamental question is who do you side with? The leading CLSN expert (Magicsia) from the online trading community? He was also one of the biggest CLSN bulls. Here's his 2.03 clsn wrap up blog post where he states that he thinks it's going bankrupt.
http://celsion.blogspot.ca/2013/02/debate-comes-to-swift-end-bears-win.html?spref=tw
Well a bunch of people on twitter are expecting to it to trade under $1.00. Magicsia the leading CLSN expert indicated in his CLSN wrap-up blog post that he thinks it's going bankrupt
Yes, that is a common occurrence where the finance buyer gets some sort of discount to share price. The thing on MELA tho, is if the company was confident in it's q4 #'s being reported March 5, they could have kept on using the ATM for the $6.6m it had remaining on it at prices of 1.50-1.70, and then when the great q4 sales #'s came out, the stock price would move upwards, and then the company could do the same financing but at a better price. Since they did not do this however, are they not confident in the q4 sales #'s?
Anybody think this holds 1.50? I think it's going to the offering price? I'm suspecting the sales are behind the company's set targets with the CEO financing at a 23% discount to yesterday's close (1.69) and was desperate to get this raise in? That's what it seems to me, any other perspectives?
Magiscia in his blog post wrap-up on CLSN thinks it's going bankrupt. They had 37c share of assets less liabilities as of 9.30.
Magiscia's blog post: http://celsion.blogspot.ca/2013/02/debate-comes-to-swift-end-bears-win.html?spref=tw
Weren't a lot of these lawsuits filed after the trial failure in April 2012 tho? this seems to me to just be an additional one filed after seeing the stock price shoot up
when was this price target update announced specifically?
Time to short was over 9.00/share. It's at 7.00 now. Could be time to go long to play the bounce up if you are a trader.
MELA, JPMorgan Chase acquired a 5.7% stake in the company. Can be considered a 'value investment' for them with stock being at all-time low range since IPO at under 2.00/share here. http://ih.advfn.com/p.php?pid=nmona&article=55982799
Why was the form 4 buy reported around 15-20 business days late? Buy was on 12.19. SEC requires it filed within 2 business days. Which was Friday 12.21.
8-k out today, indicates new investor presentation.
a) share o/s has increased..now 243m. Was 154m on on 8.17 per the 8.20 10-q. Can something be done to freeze the issuance of new shares? Ie. such as director and officer form 4 buying which could double or triple the stock price, and
b) in the Boeing deal, PSID is the exclusive provider of monthly reagents/assays. Why did PSID sell the exclusive manufacturing and distribution rights for M-Band for only 2.5$m? Why not at least double that, ie. 5$m? 2.5$m seems way too low to me.
c) only 15-20% net margins expected. So 75-80% expense on cost of goods sold? Isn't that kinda high?
a) good, but how did you know it would go red tho? b) are you going to re-add the same shares at a lower cost-basis now?
Why did you stop out? With it being at all-time low ranges under 2.00/share here, it's a value investment. The lower it goes, the more the risk gets priced out.
The #1 catalyst on MELA is it's q4 report. Sales and how much of a loss for q4. Per the comments by CEO and CFO's comments, it looks to me that q4 will be their highest sales quarter ever since launch: http://seekingalpha.com/article/988921-mela-sciences-management-discusses-q3-2012-results-earnings-call-transcript
MELA in an uptrend today so far. Higher low versus yesterday's all-time low of 1.65. I'm looking for over 2.00 buy next week as long as SPY is healthy.
MELA I think has finally bottomed at 1.65 here. Going to bounce to 2.00+ I think. #1 cheapest biotech stock I am aware of on a technical analysis basis.
Uh,,it was clear to those in the loop, it was published on The Street, http://www.cnbc.com/id/100328124
How do you know that's Sheff????
Thanks. I wonder why Silverman wants to remove the taxability from his name. The proceeds will still be taxed under the trust no?
Also i don't see why Silverman would want to escape sec reporting requirements. What's the big deal if people know how many shares he's long?
Pisd: thanks for the reply.
A) thanks Ihub,,,you guys are missing the 10.02 13d/a that you linked,,that's why i never saw that one....(geez, i hate when they are missing filings).
b) i see on the 60k
c) what's the name of the company that Silverman now is CEO at? We could contact him there to ask why he is not holding his shares...why would silverman be "gifting his shares to irrevocable trusts"...who owns these trusts?
Pisd: <Puts him under the requirement to file for this entity> that's incorrect! Per the 13d/a himself man, he still owns 6.75% directly (and 1.45% indirectly).
<which seems consistent with the significant "gifts" to "irrevocable trusts"> Huh? I've never seen any filings showing him disposing his shares to either of these 2 vehicles. Proof please Pisd?
<He still owns approx. 20% of the company,> Same thing,,proof req'd..i don't buy this...
And regarding him selling $60k,,that's false. He sold about $575k worth. He owned 23,773,263 per the prior 13d/a (7.19). He owns 12,174,371 per this 11.30 one. The difference multiplied by 2c/share is $575,485.
So, form 13d/a out,,,why has Silverman been selling more shares? Doesn't he think the company is undervalued at cap of around $2.5m?
UNIS has never changed names as far as i know of. And companies that are frauds don't really ever tend to put their money where their mouth is (ie. form 4 buying).
So, i asked you what red flags you see, then you just said "ignore me",,,thanks really nice..way to help out a fellow ihub investor..
Haha, y is that? I wanna hear what your concerns are w the company + stock! I like to do d.d. wherever it leads.
No, let's discuss lol. So what red flags do you see? I'm already aware of the selling of the RSU's that occurred. What else are you seeing? I like to be an informed investor. Maybe you have something that i haven't seen.